|
|
Volumn 38, Issue , 1992, Pages 171-297
|
|
The new generation of monoamine oxidase inhibitors
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1 ETHYLPHENOXATHIIN 10,10 DIOXIDE;
2 (3,4 DIMETHOXYPHENYL) 3 FLUOROALLYLAMINE;
ALMOXATONE;
AMIFLAMINE;
AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A;
AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B;
BAZINAPRINE;
BETA FLUOROMETHYLENE META TYROSINE;
BETA FLUOROMETHYLENEDOPAMINE;
BROFAROMINE;
CIMOXATONE;
CLORGYLINE;
HARMALINE;
IPRONIAZID;
ISOCARBOXAZID;
LAZABEMIDE;
LEVODOPA;
LILLY 54761;
MOCLOBEMIDE;
MOFEGILINE;
MONOAMINE OXIDASE INHIBITOR;
N (2 AMINOETHYL) 4 CHLOROBENZAMIDE;
N (2 AMINOETHYL) 5 (3 FLUOROPHENYL) 4 THIAZOLECARBOXAMIDE;
N (2 PROPYNYL) 1 INDANAMINE;
N [2 (2 CHLOROPHENOXY)ETHYL]CYCLOPROPYLAMINE;
NIALAMIDE;
PARGYLINE;
PHENELZINE;
SELEGILINE;
TOLOXATONE;
TRANYLCYPROMINE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
BRAIN REGION;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DEPRESSION;
GENETICS;
HUMAN;
HUMAN EXPERIMENT;
HYPERTENSION;
INTRAPERITONEAL DRUG ADMINISTRATION;
NONHUMAN;
NORMAL HUMAN;
ORAL DRUG ADMINISTRATION;
PARKINSON DISEASE;
RAT;
REVIEW;
|
|
EID: 0026520063
PISSN: 0071786X
EISSN: None
Source Type: Book Series
DOI: 10.1007/978-3-0348-7141-9_3 Document Type: Review |
|
Times cited : (263)
|
|
References (0)
|
